The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach.
about
Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics.Investigating clinically adequate concentrations of oseltamivir carboxylate in end-stage renal disease patients undergoing hemodialysis using a population pharmacokinetic approach.Population pharmacokinetics of oseltamivir in non-pregnant and pregnant women.Pharmacokinetic considerations in the use of antivirals in neonates.Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants.Pharmacokinetics of Oral and Intravenous Oseltamivir Treatment of Severe Influenza B Virus Infection Requiring Organ Replacement Therapy.
P2860
The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The posology of oseltamivir in ...... tion pharmacokinetic approach.
@en
The posology of oseltamivir in ...... tion pharmacokinetic approach.
@nl
type
label
The posology of oseltamivir in ...... tion pharmacokinetic approach.
@en
The posology of oseltamivir in ...... tion pharmacokinetic approach.
@nl
prefLabel
The posology of oseltamivir in ...... tion pharmacokinetic approach.
@en
The posology of oseltamivir in ...... tion pharmacokinetic approach.
@nl
P2093
P2860
P356
P1476
The posology of oseltamivir in ...... ation pharmacokinetic approach
@en
P2093
C R Rayner
D W Kimberlin
E P Acosta
L Gibiansky
P J Sánchez
P2860
P304
P356
10.1038/CLPT.2014.120
P407
P50
P577
2014-05-27T00:00:00Z